The most enriched oncogenic pathway in breast NET was PI3K (51%) and then RTK-RAS (45%) and this enrichment was found in 36% and 55% of samples for PI3K and RTK-RAS, respectively (Fig. 4A). The gene discussed is PIK3CA; the disease is breast neuroendocrine neoplasm.